Imatinib medac
imatinib
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What Imatinib medac is and what it is used for
What you need to know before you take Imatinib medac
How to take Imatinib medac
Possible side effects
How to store Imatinib medac
Medicinal product no longer authorised
Contents of the pack and other information
Imatinib medac is a medicine containing an active substance called imatinib. This medicine works by inhibiting the growth of abnormal cells in the diseases listed below. These include some types of cancer.
Leukaemia is a cancer of white blood cells. These white cells usually help the body to fight infection. Acute lymphoblastic leukaemia is a form of leukaemia in which certain abnormal white cells (named lymphoblasts) start growing out of control. Imatinib medac inhibits the growth of these cells.
Newly diagnosed CML for whom bone marrow transplantation is not considered as the first line of treatment;
CML in the chronic phase after failure of interferon-alpha therapy, or in the accelerated phase.
Accelerated phase is an intermediate phase among the chronic phase and the onset of blast crisis; it is considered as the first manifestation of resistance to therapy.
In the rest of this leaflet, we will use the abbreviations when talking about these diseases.
If you have any questions about how Imatinib medac works or why this medicine has been prescribed for you, ask your doctor.
Imatinib medac will only be prescribed to you by a doctor with experience in medicines to treat blood cancers or solid tumours.
Follow all your doctor’s instructions carefully, even if they differ from the general information contained in this leaflet.
Medicinal product no longer authorised
if you are allergic to imatinib or any of the other ingredients of this medicine (listed in section 6).
If this applies to you, tell your doctor without taking Imatinib medac.
If you think you may be allergic but are not sure, ask your doctor for advice.
Talk to your doctor before taking Imatinib medac:
if you have or have ever had a liver, kidney or heart problem.
if you are taking the medicine levothyroxine because your thyroid has been removed.
if you have ever had or might now have a hepatitis B infection. This is because Imatinib medac could cause hepatitis B to become active again, which can be fatal in some cases. Patients will be carefully checked by their doctor for signs of this infection before treatment is started.
If any of these apply to you, tell your doctor before taking Imatinib medac.
While you are taking Imatinib medac, your doctor will regularly check whether the medicine is working. You will also have blood tests and be weighed regularly.
Imatinib medac is also a treatment for children and adolescents with CML. There is no experience in children with CML below 2 years of age. There is limited experience in children and adolescents with
Ph-positive ALL.
Some children and adolescents taking Imatinib medac may have slower than normal growth. The doctor will monitor the growth at regular visits.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription (such as paracetamol) and including
herbal medicines (such as St. John’s Wort). Some medicines can interfere with the effect of Imatinib medac when taken together. They may increase or decrease the effect of Imatinib medac, either
leading to increased side effects or making Imatinib medac less effective. Imatinib medac may do the same to some other medicines.
Tell your doctor if you are using medicines that prevent the formation of blood clots.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Imatinib medac is not recommended during pregnancy unless clearly necessary as it may harm your baby. Your doctor will discuss with you the possible risks of taking Imatinib medac during pregnancy.
Women who might become pregnant are advised to use effective contraception during treatment.
Do not breast-feed during the treatment with Imatinib medac as there is limited information on the distribution of imatinib into the breast milk.
Patients who are concerned about their fertility while taking Imatinib medac are advised to consult with their doctor.
You may feel dizzy or drowsy or get blurred vision while taking this medicine. If this happens, do not
drive or use any tools or machines until you are feeling well again.
Medicinal product no longer authorised
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Your doctor has prescribed Imatinib medac because you suffer from a serious condition. Imatinib medac can help you to fight this condition.
However, always take this medicine exactly as your doctor, pharmacist or nurse has told you. It is important that you do this as long as your doctor, pharmacist or nurse tells you to. Check with your
doctor, pharmacist or nurse if you are not sure.
Do not stop taking Imatinib medac unless your doctor tells you to. If you are not able to take the medicine as your doctor prescribed or you feel you do not need it anymore, contact your doctor straight away.
Your doctor will tell you exactly how many capsules of Imatinib medac to take.
The usual starting dose in treatment in CML in blast crisis is 600 mg, to be taken as 6 capsules of 100 mg (or 1 capsule of 400 mg plus 2 capsules of 100 mg) once a day.
Your doctor may prescribe a higher or lower dose depending on how you respond to treatment. If your daily dose is 800 mg, you should take 1 capsule of 400 mg in the morning and 1 capsule of 400 mg in the evening.
The starting dose is 600 mg to be taken as 6 capsules of 100 mg (or 1 capsule of 400 mg plus 2 capsules of 100 mg) once a day.
The starting dose is 400 mg, to be taken as 1 capsule of 400 mg once a day.
The starting dose is 100 mg, to be taken as 1 capsule of 100 mg once a day. Your doctor may
decide to increase the dose to 400 mg, to be taken as 1 capsule of 400 mg once a day, depending on how you respond to treatment.
The dose is 800 mg per day, to be taken as 1 capsule of 400 mg in the morning and 1 capsule of
400 mg in the evening.
The doctor will tell you how many capsules of Imatinib medac to give to your child. The amount of
Imatinib medac given will depend on your child’s condition, body weight and height. The total daily dose in children and adolescents must not exceed 800 mg with CML and 600 mg with Ph+ALL. The
treatment can either be given to your child as a once-daily dose or alternatively the daily dose can be
split into two administrations (half in the morning and half in the evening).
Medicinal product no longer authorised
If you are unable to swallow the capsules, you can open them up and pour the powder into a glass of still mineral water or apple juice.
If you are a woman who is pregnant or might get pregnant and are trying to open the capsules for your children or another patient unable to swallow, you should handle the contents with caution in order to avoid skin-eye contact or inhalation. You should wash your hands immediately after opening the capsules.
Keep taking Imatinib medac every day for as long as your doctor tells you.
If you have accidentally taken too many capsules, talk to your doctor straight away. You may require medical attention. Take the medicine pack with you.
If you forget a dose, take it as soon as you remember. However if it is nearly time for the next dose, skip the missed dose.
Then continue with your normal schedule.
Do not take a double dose to make up a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. They are usually mild to moderate.
Rapid weight gain. Imatinib medac may cause your body to retain water (severe fluid retention).
Signs of infection such as fever, severe chills, sore throat or mouth ulcers. Imatinib medac can reduce the number of white blood cells, so you might get infections more easily.
Unexpected bleeding or bruising (when you have not hurt yourself).
Chest pain, irregular heart rhythm (signs of heart problems).
Cough, having difficulty breathing or painful breathing (signs of lung problems).
Feeling light-headed, dizzy or fainting (signs of low blood pressure).
Feeling sick (nausea), with loss of appetite, dark-coloured urine, yellow skin or eyes (signs of liver problems).
Rash, red skin with blisters on the lips, eyes, skin or mouth, peeling skin, fever, raised red or purple skin patches, itching, burning sensation, pustular eruption (signs of skin problems).
Severe abdominal pain, blood in your vomit, stools or urine, black stools (signs of gastrointestinal disorders).
Severely decreased urine output, feeling thirsty (signs of kidney problems).
Feeling sick (nausea) with diarrhoea and vomiting, abdominal pain or fever (signs of bowel problems).
Severe headache, weakness or paralysis of limbs or face, difficulty speaking, sudden loss of consciousness (signs of nervous system problems such as bleeding or swelling in skull/brain).
Medicinal product no longer authorised
Pale skin, feeling tired and breathlessness and having dark urine (signs of low levels of red blood cells).
Eye pain or deterioration in vision, bleeding in the eyes.
Pain in your hips or difficulty walking.
Numb or cold toes and fingers (signs of Raynaud’s syndrome).
Sudden swelling and redness of the skin (signs of a skin infection called cellulitis).
Difficulty hearing.
Muscle weakness and spasms with an abnormal heart rhythm (signs of changes in the amount of potassium in your blood).
Bruising.
Stomach pain with feeling sick (nausea).
Muscle spasms with a fever, red-brown urine, pain or weakness in your muscles (signs of muscle problems).
Pelvic pain sometimes with nausea and vomiting, with unexpected vaginal bleeding, feeling dizzy or fainting due to low blood pressure (signs of problems with your ovaries or womb).
Nausea, shortness of breath, irregular heartbeat, clouding of urine, tiredness and/or joint discomfort associated with abnormal laboratory test results (eg. high potassium, uric acid and calcium levels and low phosphorus levels in the blood).
Combination of a widespread severe rash, feeling sick, fever, high level of certain white blood cells or yellow skin or eyes (signs of jaundice) with breathlessness, chest pain/discomfort, severely decreased urine output and feeling thirsty etc. (signs of a treatment-related allergic reaction).
Chronic renal failure.
If you get any of the above, tell your doctor straight away.
Headache or feeling tired.
Feeling sick (nausea), being sick (vomiting), diarrhoea or indigestion.
Rash.
Muscle cramps or joint, muscle or bone pain, during Imatinib medac treatment or after you have stopped taking Imatinib medac
Swelling such as round your ankles or puffy eyes.
Weight gain.
If any of these affects you severely, tell your doctor.
Anorexia, weight loss or a disturbed sense of taste.
Feeling dizzy or weak.
Difficulty in sleeping (insomnia).
Discharge from the eye with itching, redness and swelling (conjunctivitis), watery eyes or having blurred vision.
Nose bleeds.
Pain or swelling in your abdomen, flatulence, heartburn or constipation.
Itching.
Unusual hair loss or thinning.
Numbness of the hands or feet.
Medicinal product no longer authorised
Mouth ulcers.
Joint pain with swelling.
Dry mouth, dry skin or dry eye.
Decreased or increased skin sensitivity.
Hot flushes, chills or night sweats.
If any of these affects you severely, tell your doctor.
Reddening and/or swelling on the palms of the hands and soles of the feet which may be accompanied by tingling sensation and burning pain.
Slowing of growth in children and adolescents.
Recurrence (reactivation) of hepatitis B infection when you have had hepatitis B in the past (a liver infection).
If any of these affects you severely, tell your doctor.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via thenationalreporting systemlistedinAppendixV. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. Do not store above 30 °C.
Do not use any pack that is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is imatinib (as mesilate).
Each 100 mg hard capsule of Imatinib medac contains 100 mg imatinib (as mesilate). Each 400 mg hard capsule of Imatinib medac contains 400 mg imatinib (as mesilate).
The other ingredients are crospovidone (type A), lactose monohydrate, magnesium stearate.
The capsule shell for 100 mg capsule is composed of gelatine, yellow iron oxide (E172), titanium dioxide (E171) and red iron oxide (E172).
The capsule shell for 400 mg capsule is composed of gelatine, yellow iron oxide (E172),
titanium dioxide (E171), red iron oxide (E172) and black iron oxide (E172).
Imatinib medac 100 mg hard capsules are gelatin capsules of size “3” with orange body and cap.
Imatinib medac 400 mg hard capsules are gelatin capsules of size “00” with caramel body and cap. Imatinib medac 100 mg capsules are supplied in packs containing 60 capsules in blisters.
Imatinib medac 400 mg capsules are supplied in packs containing 30 capsules in blisters.
medac
Medicinal product no longer authorised
Gesellschaft für klinische Spezialpräparate mbH Theaterstr. 6
22880 Wedel
Germany
Pabianickie Zakłady Farmaceutyczne Polfa S.A. Marszałka Józefa Piłsudskiego 5
95-200 Pabianice Poland
medac
Gesellschaft für klinische Spezialpräparate mbH Theaterstr. 6
22880 Wedel Germany
